A new Covid-19 vaccine soon to be approved in Australia appears to be even better than all others on offer, with new data showing it could prevent all deaths from the virus.
Trial data from the UK shows the Novavax jab stops 96 per cent of infections and 100 per cent of serious illness and death from the original version of coronavirus.
Australia has ordered 51 million doses of the jab, but it has not yet been approved by regulators.
The vaccine was also about 86 per cent effective in stopping the more contagious UK strain of Covid-19, which has caused havoc in several Australian hotel quarantine systems.
It was about 90 per cent effective overall, combining data from people infected with both versions of the coronavirus.
In a smaller trial conducted in South Africa – where volunteers were primarily exposed to another newer, more contagious variant widely circulating there and spreading around the world – the Novavax vaccine was only around 55 per cent effective at stopping infection but still fully prevented severe illness and death.
Results from the final analysis of the UK trial were largely in line with interim data released in January.
Australia is currently rolling out the Pfizer and AstraZeneca jabs, which are both very effective at stopping serious illness.
People who have received a vaccine can be given another type of jab later if it proves to be a more effective combination.
It comes after Health Department boss Brendan Murphy confirmed all Australians will not get both jabs by October.
But Professor Murphy said a solitary shot of AstraZeneca’s Covid-19 jab – rather than two – will be enough to ‘completely vaccinate’ the population by then.
Speaking on Thursday, Professor Murphy admitted the target of four million vaccinations by next month also won’t be achieved.
He said ‘global supply issues’ with a number of European countries – including Italy blocking the export of a shipment of 250,000 doses to Australia – was the reason for the delay.
Australia had been expecting 3.8 million doses of AstraZeneca vaccine from Europe in March, but so far only 700,000 doses have arrived – leaving a 3.1 million shortfall.
The vaccine was also about 86 per cent effective in stopping the more contagious UK strain of Covid-19, which has caused havoc in several Australian hotel quarantine systems.
It was about 90 per cent effective overall, combining data from people infected with both versions of the coronavirus.
In a smaller trial conducted in South Africa – where volunteers were primarily exposed to another newer, more contagious variant widely circulating there and spreading around the world – the Novavax vaccine was only around 55 per cent effective at stopping infection but still fully prevented severe illness and death.
Results from the final analysis of the UK trial were largely in line with interim data released in January.
Australia is currently rolling out the Pfizer and AstraZeneca jabs, which are both very effective at stopping serious illness.
People who have received a vaccine can be given another type of jab later if it proves to be a more effective combination.
It comes after Health Department boss Brendan Murphy confirmed all Australians will not get both jabs by October.
But Professor Murphy said a solitary shot of AstraZeneca’s Covid-19 jab – rather than two – will be enough to ‘completely vaccinate’ the population by then.
Speaking on Thursday, Professor Murphy admitted the target of four million vaccinations by next month also won’t be achieved.
He said ‘global supply issues’ with a number of European countries – including Italy blocking the export of a shipment of 250,000 doses to Australia – was the reason for the delay.
Australia had been expecting 3.8 million doses of AstraZeneca vaccine from Europe in March, but so far only 700,000 doses have arrived – leaving a 3.1 million shortfall.
Image Credit: Novavax
Post by Amanda Scott, NA CEO. Follow her on twitter @tantriclens
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen

News
DREAM complex could hold key to fighting cancer and living longer
DNA may be the stuff of life, but if it isn't repaired in our bodies on a regular basis, it can lead to diseases that can cause some pretty unpleasant types of death. DNA [...]
A Promising New Pathway in the Battle Against Aggressive Prostate Cancer
Neuronal Molecule Makes Prostate Cancer More Aggressive Researchers discover a potential therapeutic avenue against an aggressive form of prostate cancer. Prostate cancer is the second most common cancer and the second leading cause of [...]
Nasal Vaccines: Stopping the COVID-19 Virus Before It Reaches the Lungs
The Pfizer-BioNTech and Moderna mRNA vaccines have played a large role in preventing deaths and severe infections from COVID-19. But researchers are still in the process of developing alternative approaches to vaccines to improve [...]
NASA Tracking a Huge, Growing Anomaly in Earth’s Magnetic Field – with video
NASA is actively monitoring a strange anomaly in Earth's magnetic field: a giant region of lower magnetic intensity in the skies above the planet, stretching out between South America and southwest Africa. This vast, developing [...]
New, Better Models Show How Infectious Diseases Like COVID-19 Spread
Infectious diseases such as COVID-19 can spread rapidly across the globe. Models that can predict how such diseases spread will strengthen national surveillance systems and improve public health decision-making. The COVID-19 pandemic has emphasized the [...]
Human Antibodies Discovered That Can Block Multiple Coronaviruses Including COVID-19
Results from a Scripps Research and UNC team pave the way for a vaccine and therapeutic antibodies that could be stockpiled to fight future coronavirus pandemics. A team of scientists from Scripps Research and [...]
Nanotechnology could be used to treat lymphedema
The human body is made up of thousands of tiny lymphatic vessels that ferry white blood cells and proteins around the body, like a superhighway of the immune system. It's remarkably efficient, but if [...]
DNA Nanotechnology Tools – From Design to Applications
Suite of DNA nanotechnology devices engineered to overcome specific bottlenecks in the development of new therapies, diagnostics, and understanding of molecular structures. DNA nanostructures with their potential for cell and tissue permeability, biocompatibility, and [...]
Regenerating bone with deer antler stem cells
Scientists from a collection of Chinese research institutions collaborated on a study of organ regeneration in mammals, finding deer antler blastema progenitor cells are a possible source of conserved regeneration cells in higher vertebrates. [...]
AI Takes On Cancer: Analysis of Mutations Could Lead to Improved Therapy
Cancer is a complex and diverse disease, and its range of associated mutations is vast. The combination of these genomic changes in an individual is referred to as their “mutational landscape.” These landscapes vary [...]
Exposing tumours to bacteria converts immune cells to cancer killers
New research on inflammation could lead to better treatments to improve outcomes for people with advanced or previously untreatable cancers. Introducing bacteria to a tumour’s microenvironment creates a state of acute inflammation that triggers [...]
Smart nanotechnology for more accurate delivery of insulin
More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to measure their glucose levels could be a step closer thanks to a Monash University-led project. Published [...]
Efficiently Harvesting Rare Earth Elements From Wastewater Using Exotic Bacteria
The novel strains of cyanobacteria exhibit a fast and efficient “biosorption” of rare earth elements, making recycling possible. Rare earth elements (REEs) are a set of 17 metallic elements that possess similar chemical properties. [...]
Resisting Treatment: Cancer Cells Shrink or Super-Size To Survive
A new approach to image analysis has uncovered how cancer cells manipulate their size as a means of resisting treatment. Researchers have discovered that cancer cells are capable of either shrinking or super-size themselves [...]
New Research Explains Why Children Avoid Severe COVID-19 Symptoms
According to new research, children exhibit a robust initial immune response to the coronavirus, however, they are unable to transfer this response to long-lasting memory T cells like adults do. Researchers led by scientists [...]
Scientists Unravel Protein Map of Mitochondria
A new study sheds light on the organization of proteins within mitochondria. Mitochondria, the “powerhouses” of cells, play a crucial role in the energy production of organisms and are involved in various metabolic and [...]